Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD: Case 1
Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD
Watch
Charles Fuchs, MD: Mutations in Colorectal Cancer
Charles Fuchs, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Charles Fuchs, MD: Treatment Toxicities and Quality of Life
Charles Fuchs, MD: Chemotherapy Side-Effects
Charles Fuchs, MD: Bevacizumab Side-Effects
Charles Fuchs, MD: Bevacizumab Plus Chemotherapy
Charles Fuchs, MD: First-Line Treatments in Unresectable Colon Cancer
Tanios Bekaii-Saab, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Tanios Bekaii-Saab, MD: Treatment Toxicities and Quality of Life
Tanios Bekaii-Saab, MD: Chemotherapy Side-Effects
Tanios Bekaii-Saab, MD: Bevacizumab Side-Effects
Tanios Bekaii-Saab, MD: Bevacizumab Plus Chemotherapy
Tanios Bekaii-Saab, MD: First-Line Treatments in Unresectable Colon Cancer
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD: Case 2
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD
Adam Brufsky, MD, PhD: Clinical Trial Data Supporting These Choices
Adam Brufsky, MD, PhD: Expectations of Therapy in Breast Cancer
Adam Brufsky, MD, PhD: Considerations for Different Therapies in Breast Cancer
Adam Brufsky, MD, PhD: Choices of Therapy in Breast Cancer
Kimberly Blackwell, MD: Clinical Trial Data Supporting These Choices
Kimberly Blackwell, MD: Expectations of Therapy in Breast Cancer
Kimberly Blackwell, MD: Considerations for Different Therapies in Breast Cancer
Kimberly Blackwell, MD: Choices of Therapy in Breast Cancer
Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma
Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.
Dr. Anne Covey on Locoregional Therapy in Hepatocellular Carcinoma
Anne Covey, MD, discusses options for patients with hepatocellular carcinoma (HCC) who cannot undergo resection or transplant.
Dr. Louis Harrison on Immunotherapy and Radiation Therapy Combinations
Louis B. Harrison, discusses the recent opportunities to combine radiation therapy and immunotherapy.
Dr. Mahmoud Al-Hawary on NCCN Imaging Guidelines and Their Role in Pancreatic Cancer
Mahmoud Al-Hawary, MD, discusses the current NCCN guidelines for imaging and how they play a role in patients with pancreatic cancer.
Dr. Tuya Pal on Genetic Risk Assessment in Ovarian Cancer
Tuya Pal, MD, discusses the importance of genetic risk assessment shaping management guidelines in ovarian cancer.
Dr. Jeffrey Jones on Idelalisib and Ibrutinib in Patients With CLL
Jeffrey Jones, MD, discusses treatment options for patients with chronic lymphocytic leukemia (CLL) who progress on, or become intolerant of, idelalisib or ibrutinib during their treatment.
Dr. Eytan Stein on Multiple Targets in Acute Myeloid Leukemia
Eytan Stein, MD, discusses targeting multiple mutations in patients with acute myeloid leukemia (AML).
